ArticleActive
Response to Comments: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
A59197
Effective: September 1, 2022
Updated: December 31, 2025
Policy Summary
The provided document A59197 is a response-to-comments summary related to proposed LCD DL38229 (GIP panels using multiplex NAATs) and does not contain the actual coverage criteria. Review of the final Local Coverage Determination DL38229 is required to extract specific indications, limitations, documentation requirements, and frequency limits.
Coverage Criteria Preview
Key requirements from the full policy
"Source document contains only comment summaries and contractor responses regarding proposed LCD DL38229 and does not include coverage criteria; full text of final LCD DL38229 is required to extract..."
Sign up to see full coverage criteria, indications, and limitations.